Cargando…
Early Quantification of Salivary Gland Function after Radioiodine Therapy
PURPOSE OF THE STUDY: Radioiodine (I-131) is used as an effective noninvasive treatment for thyroid malignancies. Salivary gland is one of the most affected nontarget organs. The present study aims to perform early quantification of salivary gland function after I-131 therapy (RIT) for thyroid cance...
Autores principales: | Tanwar, Karan Singh, Rana, Nivedita, Mittal, Bhagwant Rai, Bhattacharya, Anish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8130693/ https://www.ncbi.nlm.nih.gov/pubmed/34040292 http://dx.doi.org/10.4103/ijnm.IJNM_158_20 |
Ejemplares similares
-
Radioiodine treatment in McCune–Albright syndrome with hyperthyroidism
por: Chakraborty, Dhritiman, et al.
Publicado: (2012) -
Utility of Iodine-131 hybrid SPECT-CT fusion imaging before high-dose radioiodine therapy in papillary thyroid carcinoma
por: Bhattacharya, Anish, et al.
Publicado: (2010) -
Role of single photon emission computed tomography/computed tomography in diagnostic iodine-131 scintigraphy before initial radioiodine ablation in differentiated thyroid cancer
por: Agrawal, Kanhaiyalal, et al.
Publicado: (2015) -
A rare case of asymptomatic radioiodine-avid renal and brain metastases 20 years after hemi-thyroidectomy for adenomatous goiter
por: Santhosh, Sampath, et al.
Publicado: (2016) -
Primary autoimmune thrombocytopenia and co-existing Graves’ disease: Role of radioiodine-131
por: Jung, Rayamajhi Sampanna, et al.
Publicado: (2014)